What is Adapttech?
Adapttech operates within the biomedical industry, focusing on the development of innovative technologies designed to empower healthcare providers. Their core mission revolves around creating solutions that improve the lives of people facing physical limitations. The company's commitment to this mission is reflected in its consistent pursuit of strategic capital to fuel its research, development, and market expansion efforts.
How much funding has Adapttech raised?
Adapttech has raised a total of $6.6M across 3 funding rounds:
Other Financing Round
$915K
Other Financing Round
$2.8M
Unspecified
$2.9M
Other Financing Round (2018): $915K, investors not publicly disclosed
Other Financing Round (2021): $2.8M led by Wealth Club, Wren Capital, ACF Investors, Bionova Capital, and Midlands Engine
Unspecified (2022): $2.9M supported by EIS funds, MEIF Proof of Concept & Early Stage Fund, and Wealth Club
Key Investors in Adapttech
Wren Capital
Wren Capital is an angel investor specializing in science, engineering, and software, founded in 2011 with over 60 investments. They focus on sectors such as software, semiconductors, medical devices, and others requiring technical ingenuity. Wren typically invests between £50,000 to £200,000 per funding round, emphasizing a pragmatic approach to deal-making.
Wealth Club
Wealth Club is an investment platform that provides access to a range of investment opportunities, often focusing on tax-efficient products like ISAs and SIPPs. Their involvement suggests an interest in companies with growth potential that can appeal to a broad investor base.
Bionova Capital
Bionova Capital is an investment firm that typically focuses on the life sciences and healthcare sectors. Their participation indicates a strategic alignment with Adapttech's mission in the biomedical field.
What's next for Adapttech?
With a history of securing substantial investment, Adapttech appears poised for continued expansion and technological advancement. The recent major strategic investment suggests a strong validation of its business model and future potential by its backers. This infusion of capital will likely be directed towards scaling operations, further refining its product offerings, and potentially exploring new market segments. The company's trajectory indicates a focus on solidifying its position as a leader in assistive technologies.
See full Adapttech company page
